All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
CAT | Product Name | Target Species | Antibody Clone | Antibody Host | Receptor Construction | Vector Type | Targeting Cell Type | CAR Vector Type | Inquiry & Datasheet |
XS-0622-ZP3246 | Anti-NANOG h(VHH1-VHH2-CD28-CD3ζ) Biepitopic CAR, pCDCAR1 | Human | VHH1-VHH2-CD28-CD3ζ | Lentiviral vector | T Cell | ||||
XS-0822-YF714 | Anti-Human NANOG (XW-714) h(41BB-CD3ζ) CAR IVT Plasmid, pCARIVT | Human | XW-714 | Mouse | scFv-41BB-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF715 | Anti-Human NANOG (XW-715) h(41BB-CD3ζ) CAR IVT Plasmid, pCARIVT | Human | XW-715 | Rabbit | scFv-41BB-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF716 | Anti-Human NANOG (XW-716) h(41BB-CD3ζ) CAR IVT Plasmid, pCARIVT | Human | XW-716 | Rabbit | scFv-41BB-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF717 | Anti-Mouse NANOG (XW-717) m(41BB-CD3ζ) CAR IVT Plasmid, pCARIVT | Mouse | XW-717 | Rabbit | scFv-41BB-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF1634 | Anti-Human NANOG (XW-714) h(CD28-CD3ζ) CAR IVT Plasmid, pCARIVT | Human | XW-714 | Mouse | scFv-CD28-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF1635 | Anti-Human NANOG (XW-715) h(CD28-CD3ζ) CAR IVT Plasmid, pCARIVT | Human | XW-715 | Rabbit | scFv-CD28-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF1636 | Anti-Human NANOG (XW-716) h(CD28-CD3ζ) CAR IVT Plasmid, pCARIVT | Human | XW-716 | Rabbit | scFv-CD28-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF1637 | Anti-Mouse NANOG (XW-717) m(CD28-CD3ζ) CAR IVT Plasmid, pCARIVT | Mouse | XW-717 | Rabbit | scFv-CD28-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF2554 | Anti-Human NANOG (XW-714) h(CD28-41BB-CD3ζ) CAR IVT Plasmid, pCARIVT | Human | XW-714 | Mouse | scFv-CD28-41BB-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF2555 | Anti-Human NANOG (XW-715) h(CD28-41BB-CD3ζ) CAR IVT Plasmid, pCARIVT | Human | XW-715 | Rabbit | scFv-CD28-41BB-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF2556 | Anti-Human NANOG (XW-716) h(CD28-41BB-CD3ζ) CAR IVT Plasmid, pCARIVT | Human | XW-716 | Rabbit | scFv-CD28-41BB-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF2557 | Anti-Mouse NANOG (XW-717) m(CD28-41BB-CD3ζ) CAR IVT Plasmid, pCARIVT | Mouse | XW-717 | Rabbit | scFv-CD28-41BB-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0123-ZP337 | Anti-NANOG (4A8) h(scFv-CD3ε) TRuC, pCDTRC1 | Human | 4A8 | Mouse | scFv-CD3ε | Lentiviral vector | T cell | ||
XS-0123-ZP339 | Anti-NANOG (CBACN-395) h(scFv-CD3ε) TRuC, pCDTRC1 | Human | CBACN-395 | Rabbit | scFv-CD3ε | Lentiviral vector | T cell | ||
XS-0123-ZP563 | Anti-NANOG (DS2363AB) h(scFv-CD3ε) TRuC, pCDTRC1 | Mouse | DS2363AB | Rabbit | scFv-CD3ε | Lentiviral vector | T cell | ||
XS-0323-ZP337 | Anti-NANOG (4A8 scFv-CD28TM-CD79β) CBCR(CAR-B), pCDCAR1 | Human | 4A8 | Mouse | scFv-CD28TM-CD79β | Lentiviral vector | T cell | CAR-B Vector | |
XS-0323-ZP338 | Anti-NANOG (CBPCN-437 scFv-CD28TM-CD79β) CBCR(CAR-B), pCDCAR1 | Human | CBPCN-437 | Rabbit | scFv-CD28TM-CD79β | Lentiviral vector | T cell | CAR-B Vector | |
XS-0323-ZP339 | Anti-NANOG (CBACN-395 scFv-CD28TM-CD79β) CBCR(CAR-B), pCDCAR1 | Human | CBACN-395 | Rabbit | scFv-CD28TM-CD79β | Lentiviral vector | T cell | CAR-B Vector | |
XS-0323-ZP563 | Anti-NANOG (DS2363AB scFv-CD28TM-CD79β) CBCR(CAR-B), pCDCAR1 | Mouse | DS2363AB | Rabbit | scFv-CD28TM-CD79β | Lentiviral vector | T cell | CAR-B Vector |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION